Results 11 to 20 of about 1,359,149 (381)

Neoplasm Transplantation Inhibition by Uninvolved Lymph Tissue [PDF]

open access: yesNature, 1966
HETEROLOGOUS transplantation of human neoplasms into the cheek pouch of the syrian hamster (Mesocricetus auratus) was first reported in 1951 (ref. 1). The uniqueness of the pouch as a site for transplantation results from the alymphatic structure and the very slow diffusion of large molecules out of the pouch area2.
B. Caldwell, P. Wright
semanticscholar   +4 more sources

Orthotopic Liver Transplantation for Benign Hepatic Neoplasms [PDF]

open access: yesArchives of Surgery, 1995
To evaluate the frequency and outcome of liver transplantation for symptomatic, unresectable, benign hepatic neoplasms.Retrospective study.Presbyterian University Hospital, a tertiary care referral center for liver transplantation affiliated with the University of Pittsburgh (Pa).All 3239 liver transplant recipients at the University of Pittsburgh from
Iwatsuki, S   +5 more
core   +3 more sources

Malignant neoplasms following cardiac transplantation [PDF]

open access: yesEuropean Journal of Cardio-Thoracic Surgery, 1997
Malignancies have long been recognized as a complication of long lasting immunosuppressive therapy. We reviewed our experience to investigate the incidence and the spectrum of non cutaneous de novo malignant neoplasms.Between March 1987 and March 1996, 296 patients underwent 303 cardiac transplantation in our service. The population at risk consists of
A. Curtil   +5 more
openaire   +3 more sources

Transduction-Transplantation Mouse Model of Myeloproliferative Neoplasm [PDF]

open access: yesJournal of Visualized Experiments, 2016
Transduction-transplantation is a quick and efficient way to model human hematologic malignancies in mice. This technique results in expression of the gene of interest in hematopoietic cells and can be used to study the gene's role in normal and/or malignant hematopoiesis.
Nguyen, Thanh Kim   +2 more
openaire   +5 more sources

Prognostic Role of Cell Blood Count in Chronic Myeloid Neoplasm and Acute Myeloid Leukemia and Its Possible Implications in Hematopoietic Stem Cell Transplantation

open access: yesDiagnostics, 2022
Numerous prognostic indexes have been developed in hematological diseases based on patient characteristics and genetic or molecular assessment. However, less attention was paid to more accessible parameters, such as neutrophils, lymphocytes, monocytes ...
Olga Mulas   +5 more
doaj   +1 more source

Treatment of a mixed acinar-endocrine carcinoma with uptake on 68Gallium-DOTATOC positron emission tomography-computed tomography : a case report [PDF]

open access: yes, 2017
The case of a 35-year old female patient with a diagnosis of metastatic mixed acinar-endocrine carcinoma (MAEC) is investigated in the present study.
De Both, Anneleen   +5 more
core   +2 more sources

Long-term results after liver transplantation for primary hepatic epithelioid hemangioendothelioma [PDF]

open access: yes, 1995
Background: Hepatic epithelioid hemangioendothelioma (PHEHE) is a multifocal, low-grade malignant neoplasia characterized by its epithelial-like appearance and vascular endothelial histogenesis.
American Joint Committee on Cancer   +21 more
core   +2 more sources

Downregulating Notch counteracts KrasG12D-induced ERK activation and oxidative phosphorylation in myeloproliferative neoplasm. [PDF]

open access: yes, 2019
The Notch signaling pathway contributes to the pathogenesis of a wide spectrum of human cancers, including hematopoietic malignancies. Its functions are highly dependent on the specific cellular context. Gain-of-function NOTCH1 mutations are prevalent in
Chang, Yuan-I   +20 more
core   +1 more source

Development of colon cancer after liver transplantation for primary sclerosing cholangitis associated with ulcerative colitis [PDF]

open access: yes, 1990
Between February 26, 1981, and July 30, 1987, 36 patients underwent orthotopic liver transplantation for primary sclerosing cholangitis associated with ulcerative colitis.
Higashi, H   +5 more
core   +1 more source

Home - About - Disclaimer - Privacy